What’s Up with Diabetes Stem Cell Research Firm ViaCyte
We were familiar with the company ViaCyte through its former identity as NovoCell, when we reported that they’d managed to successfully control diabetes in mice using embryonic stem cells back in 2008. Last year, they changed their name, but their…
We were familiar with the company ViaCyte through its former identity as NovoCell, when we reported that they’d managed to successfully control diabetes in mice using embryonic stem cells back in 2008. Last year, they changed their name, but their…
SOURCE: Healthline RSS Feed – Read entire story here.